Cytokinetics
CYTK
CYTK
253 hedge funds and large institutions have $3.55B invested in Cytokinetics in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 97 increasing their positions, 80 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 38
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
47% less call options, than puts
Call options by funds: $7.6M | Put options by funds: $14.5M
Holders
253
Holding in Top 10
7
Calls
$7.6M
Puts
$14.5M
Top Buyers
| 1 | +$33.3M | |
| 2 | +$27.5M | |
| 3 | +$27.3M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$19.3M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$18.1M |
Top Sellers
| 1 | -$34.9M | |
| 2 | -$33.9M | |
| 3 | -$26M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$22.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$18.1M |